EI
WST icon

EAM Investors’s West Pharmaceutical WST Stock Holding History

EAM Investors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-34,249
Closed -$2.6M – 368
2016
Q2 		$2.6M Buy
+34,249
New +$2.49M 0.39% 120
2014
Q1 		– Sell
-30,658
Closed -$1.5M – 353
2013
Q4 		$1.5M Buy
+30,658
New +$1.43M 0.27% 142

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EAM Investors's WST Position: Q3 2016 in Review

EAM Investors sold out of West Pharmaceutical (WST) in Q3 2016, closing a stake of 34,249 shares — an estimated $2.6M sold.

EAM Investors first reported a position in WST in Q4 2013 and held it in 2 quarters. The position peaked at $2.6M in Q2 2016. 280 funds tracked by Wall St. Rank hold WST as of Q3 2016.

  • EAM Investors reported no remaining West Pharmaceutical position as of Q3 2016 after selling out during the quarter.
  • EAM Investors sold 34,249 West Pharmaceutical shares in Q3 2016, an estimated $2.6M.
  • EAM Investors first reported a position in West Pharmaceutical in Q4 2013 and held it in 2 quarters.
  • EAM Investors's West Pharmaceutical position peaked at $2.6M in Q2 2016.
  • 280 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2016.

Based on EAM Investors's 13F filing for Q3 2016, filed 10 Nov 2016.